Literature DB >> 8095159

Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis.

T P Curran1, R Shapiro, J F Riordan.   

Abstract

The molecular basis for the enzymatic specificity of human angiogenin has been investigated by site-directed mutagenesis of Thr-44, Glu-108, and Ser-118--residues corresponding to those thought to be involved in substrate base recognition in the homologous protein, RNase A. Mutations of Thr-44 to Ala, His, and Asp affect both activity and specificity dramatically. The Ala and His replacements decrease activity toward tRNA by factors of 25 and 40, respectively, and reduce cleavage of cytidylyl more than uridylyl dinucleotides. Substitution by Asp does not influence the rate of tRNA and rRNA degradation but alters specificity even more markedly than the other mutations: T44D-angiogenin has 17-40-fold decreased activity toward CpN' dinucleotides and 1.3-1.9-fold increased activity toward UpN', resulting in an inverted order of preference (U > C) compared to native angiogenin. Mutations of Glu-108 to Lys and Gln change activity toward RNA and dinucleotides by no more than 50% and produce slight increases in preference for adenosine vs guanosine at position N' of NpN' substrates. Mutations of Ser-118 to Asp and Arg have a larger effect, decreasing activity by factors of approximately 2 and 4, respectively, toward all substrates examined. These results indicate that: (i) Thr-44 is important for recognition of the pyrimidine moiety at position N, (ii) Glu-108 may make a small contribution to binding the N'-nucleotide, and (iii) Ser-118 has a minor functional role, which appears to involve catalysis rather than nucleotide binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095159     DOI: 10.1021/bi00060a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.

Authors:  Daniel E Holloway; Gayatri B Chavali; Michelle C Hares; Vasanta Subramanian; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-11-19

2.  Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.

Authors:  A C Papageorgiou; R Shapiro; K R Acharya
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 3.  RNA decay: a novel therapeutic target in bacteria.

Authors:  Tess M Eidem; Christelle M Roux; Paul M Dunman
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-02-28       Impact factor: 9.957

4.  The C-terminal region of human angiogenin has a dual role in enzymatic activity.

Authors:  N Russo; V Nobile; A Di Donato; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Crystal structure of bovine angiogenin at 1.5-A resolution.

Authors:  K R Acharya; R Shapiro; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  A comparison of the predicted and X-ray structures of angiogenin. Implications for further studies of model building of homologous proteins.

Authors:  S C Allen; K R Acharya; K A Palmer; R Shapiro; B L Vallee; H A Scheraga
Journal:  J Protein Chem       Date:  1994-10

7.  Role of glutamine-117 in the ribonucleolytic activity of human angiogenin.

Authors:  N Russo; R Shapiro; K R Acharya; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

8.  Residues 36-42 of liver RNase PL3 contribute to its uridine-preferring substrate specificity. Cloning of the cDNA and site-directed mutagenesis studies.

Authors:  A M Vicentini; B A Hemmings; J Hofsteenge
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

9.  Mutational dynamics of murine angiogenin duplicates.

Authors:  Francisco M Codoñer; Silvia Alfonso-Loeches; Mario A Fares
Journal:  BMC Evol Biol       Date:  2010-10-15       Impact factor: 3.260

10.  Influence of naturally-occurring 5'-pyrophosphate-linked substituents on the binding of adenylic inhibitors to ribonuclease a: an X-ray crystallographic study.

Authors:  Daniel E Holloway; Gayatri B Chavali; Demetres D Leonidas; Matthew D Baker; K Ravi Acharya
Journal:  Biopolymers       Date:  2009-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.